blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4157281

EP4157281 - COMPOSITIONS AND METHODS FOR SENSITIZING ACUTE MYELOID LEUKEMIAS TO CHEMOTHERAPY [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  03.03.2023
Database last updated on 19.10.2024
FormerThe international publication has been made
Status updated on  03.12.2021
Most recent event   Tooltip28.05.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Duke University
2812 Erwin Road
Durham, NC 27705 / US
[2023/14]
Inventor(s)01 / WOOD, Kris
Durham, NC 27705 / US
02 / LIN, Kevin, H.
Durham, NC 27705 / US
03 / RUTTER, Justine
Durham, NC 27705 / US
04 / ANG, Xiaohui, Hazel
Durham, NC 27705 / US
 [2023/14]
Representative(s)Harris, Oliver John Richard
Novagraaf UK
Centrum
Norwich Research Park
Colney Lane
Norwich NR4 7UG / GB
[2023/14]
Application number, filing date21813533.326.05.2021
[2023/14]
WO2021US34255
Priority number, dateUS202063030338P27.05.2020         Original published format: US 202063030338 P
[2023/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021242859
Date:02.12.2021
Language:EN
[2021/48]
Type: A1 Application with search report 
No.:EP4157281
Date:05.04.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 02.12.2021 takes the place of the publication of the European patent application.
[2023/14]
Search report(s)International search report - published on:US02.12.2021
ClassificationIPC:A61K31/426, A61K31/519, A61K31/5377, A61P1/04, A61P9/00, A61P11/00, A61P11/06, A61K31/498, A61K45/06
[2024/26]
CPC:
A61K45/06 (EP,US); A61K31/519 (EP,US); A61K31/426 (EP);
A61K31/427 (US); A61K31/498 (EP,US); A61K31/635 (EP);
A61K31/704 (EP); A61K31/713 (EP); A61P1/04 (EP);
A61P11/00 (EP); A61P11/06 (EP); A61P9/00 (EP) (-)
C-Set:
A61K31/426, A61K2300/00 (EP);
A61K31/498, A61K2300/00 (EP);
A61K31/519, A61K2300/00 (EP);
A61K31/635, A61K2300/00 (EP);
A61K31/704, A61K2300/00 (EP);
A61K31/713, A61K2300/00 (EP)
(-)
Former IPC [2023/14]A61K31/519, A61K31/5377, A61P1/04, A61P9/00, A61P11/00, A61P11/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/14]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR SENSIBILISIERUNG VON AKUTER MYELOISCHER LEUKÄMIE AUF CHEMOTHERAPIE[2023/14]
English:COMPOSITIONS AND METHODS FOR SENSITIZING ACUTE MYELOID LEUKEMIAS TO CHEMOTHERAPY[2023/14]
French:COMPOSITIONS ET PROCÉDÉS POUR SENSIBILISER DES LEUCÉMIES MYÉLOÏDES AIGUËS À UNE CHIMIOTHÉRAPIE[2023/14]
Entry into regional phase22.11.2022National basic fee paid 
22.11.2022Search fee paid 
22.11.2022Designation fee(s) paid 
22.11.2022Examination fee paid 
Examination procedure22.11.2022Examination requested  [2023/14]
13.07.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
30.05.2023Renewal fee patent year 03
28.05.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US2010278837  (VARNER JUDITH A [US], et al);
 [X]US2015087658  (XI NING [US], et al);
 [A]US2015376188  (BHAVAR PRASHANT K [IN], et al);
 [X]US2017190689  (SPARKS RICHARD B [US], et al);
 [A]US10111897  (WOOD KRIS CAMERON [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.